Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer.

Caspian OliaiMatthew BernetichLuther BradyJun YangAlexandra HanlonJohn LamondSteven ArrigoMichael GoodMichael MoorevilleBruce GarberRachelle Lanciano

Published in: Journal of radiation oncology (2016)

Our data support the hypothesis that SBRT has non-inferior efficacy and toxicity rates as IMRT. Given the lower cost and convenience for patients, SBRT may be considered as an alternative treatment for localized prostate cancer.

Keyphrases

prostate cancer
radiation therapy
radical prostatectomy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
electronic health record
big data
deep learning